MTX

Everything you’ve always wanted to know about the use of methotrexate in sarcoidosis

Help is at hand. There’s an app for that!

This concise and useful app gives 10 recommendations on how to use methotrexate in sarcoidosis clinical practice. That’s a first!

Based on the expert opinions from the world’s leading sarcoidologists combined with evidence-based recommendations from the literature, this app provides the physician with a tremendous amount of distilled information in the use of methotrexate.
You will find recommendations from Current Opinion in Pulmonary Medicine and links to other scientific publications, along with clinical cases demonstrating the treatment and effect of methotrexate.

Methotrexate is the second-line drug of choice in cases of steroid resistance or adverse steroid reactions; it is useful as a steroid-sparing agent as well. The app was developed on behalf of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). The information will be continuously updated highlighting new, informative clinical cases. Everything you've always wanted to know about the use of methotrexate in sarcoidosis

Help is at hand. There's an app for that!

This concise and useful app gives 10 recommendations on how to use methotrexate in sarcoidosis clinical practice. That's a first!

Based on the expert opinions from the world's leading sarcoidologists combined with evidence-based recommendations from the literature, this app Provides the physician with a tremendous amount of information distilled in the use of methotrexate.
You will find recommendations from Current Opinion in Pulmonary Medicine and links to other scientific publications, alongwith clinical cases demonstrating the treatment and effect of methotrexate.

Methotrexate is the second-line drug of choice in cases of steroid resistance or steroid adverse reactions, it is useful as a steroid-sparing agent as well. The app was developed on Behalf of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). The information will be updated continuously highlighting new, informative clinical cases.